Key Details
Price
$572.31Last Dividend
$0.50Annual ROE
28.59%Beta
0.49Events Calendar
Next earnings date:
Feb 27, 2025Recent quarterly earnings:
Oct 29, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 18, 2024Next split:
N/ARecent split:
May 12, 2005Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payabl.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2024 Global Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of.
Chemed's VITAS segment reports impressive revenue growth and margin expansion for the third quarter of 2024.
The Investment Committee give you their top stocks to watch for the second half.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2024, on Tuesday, October 29, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 30, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call t.
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed continues to present with exceptional economic characteristics now at depressed valuations vs. history. The business is highly profitable and earns high rates of return on all the capital that's been employed into its operations. Management has an extensive reinvestment runway to redeploy surplus funds and grow the intrinsic worth of the business.
Morningstar.com published an interesting piece in July about the long-term health care crisis. It pointed out that Americans paid out $245 billion for long term care to paid caregivers, nursing homes and other forms of paid assistance.
Karen Firestone, chairman and CEO at Aureus Asset Management, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Chemed (CHE) possesses solid growth attributes, which could help it handily outperform the market.
FAQ
- What is the primary business of Chemed?
- What is the ticker symbol for Chemed?
- Does Chemed pay dividends?
- What sector is Chemed in?
- What industry is Chemed in?
- What country is Chemed based in?
- When did Chemed go public?
- Is Chemed in the S&P 500?
- Is Chemed in the NASDAQ 100?
- Is Chemed in the Dow Jones?
- When was Chemed's last earnings report?
- When does Chemed report earnings?
- Should I buy Chemed stock now?